Stock Ratings / Health Care / PNTG / dividends

TDOC (55) USPH (70) INNV (52) OMDA (53) ⌘ Pro Terminal →

The Pennant Group Inc. (PNTG) Dividend Safety Gauge & 10-Year DRIP Compounder

$41.66 -1.93% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $41.44

The Pennant Group Inc. (PNTG) carries a Roarable Rating of C (Hold) with 64/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

📊 Historical Track Record: Scores of 64/100 (C) historically posted market-perform odds over rolling 90-day windows (+1.1% avg 90D alpha vs SPY) →

ROARABLE C • HOLD / WATCH Cap $1.46B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on PNTG Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is PNTG stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, The Pennant Group Inc. (NASDAQ: PNTG) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 64/100 at a spot price of $41.66 (-1.93% 1D, market cap $1.46B). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 14/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 11/20. Across 1016 tracked Health Care issuers, PNTG ranks #129 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does PNTG compare to TDOC and USPH in the Health Care sector?

▼

Within the Health Care sector (Medical/Nursing Services), PNTG carries a Roarable C (64/100 RQD), trailing P/E of 50.2x, gross margin of —, and ROIC of 11.0%. By comparison, TDOC (Teladoc Health Inc.) holds a D+ grade (55/100 RQD, P/E N/A, ROIC -17.0%, cap $1.55B) and USPH (U.S. Physical Therapy Inc.) posts a B- grade (70/100 RQD, P/E 32.6x, ROIC 11.5%, cap $1.28B). Among the 5-stock peer group, USPH leads on earnings multiple (32.6x) while USPH leads on capital efficiency (11.5% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for PNTG?

▼

Per PNTG's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001766400), The Pennant Group Inc. generated $947.7M in revenue (+36.3% YoY), $29.6M in net income, and $36.3M in free cash flow against $968.2M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Priced at 50x earnings—high expectations leave less room for a lukewarm quarter.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $41.44 (-0.54%)🧬 Cannibal Buyback (-0.96% YoY Shares)⚙️ Cash Engine: 13/20 (C) • 3.8% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 64/100 (C) historically posted market-perform odds over rolling 90-day windows (+1.1% avg 90D alpha vs SPY • 55.2% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERHOLD / WATCH • C

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C · Rk C

Each axis scored 0–20

12M PRICE TARGET CONE+2.7% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for PNTG)Realized 20D OHLCV Swing Band: ±6.2%

Deterministic 5-Pillar Attribution (64/100 Composite)

🔍 WHY PNTG SCORES 64/100 (C) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+14/20 pts (22% of score)

20D Institutional Volume Accumulation (±6.2% realized swing band)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+14/20 pts (22% of score)

Altman Z-Score 2.81 (WATCH ZONE (1.8–3.0)) • Piotroski F-Score 7/9

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution11/20 pts (-9 pt drag)

Cannibal Buyback (-0.96% YoY Shares) & executive Form 4 sales trim 9 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C$40.15+3.3% Next Q

Q2 (-2Q)

Grade C$41.48+0.5% Next Q

Q3 (-1Q)

Grade C$41.67+0% Next Q

Current

Grade C$41.66+1.1% Hist 90D α

Trajectory: C (56) → C (64)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the PNTG Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 64/100 (C) score, PNTG faces multiple-compression risk if 50.2x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Priced at 50x earnings—high expectations leave less room for a lukewarm quarter.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-0.96% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($40.09) or 200D SMA ($35.56) invalidates the momentum regime and cuts Target Base ($42.78) toward Bear Floor ($33.37).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $PNTG• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “PNTG Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 64%NO 36%Trade / Inspect Odds →

CASH DIVIDEND + BUYBACK YIELD

1.8% Total Yield

0% Cash ($0.00/yr) + 1.8% Buybacks

PAYOUT SAFETY SPEEDOMETER

74/100 • REINVESTING IN GROWTH + BUYBACKS

FREE CASH FLOW PAYOUT RATIO

0% (100% Reinvested)

Retains cash flow for R&D and share repurchases

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (16.3% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $45,269

Est. Year-10 Shareholder Yield: $815/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$11.6K

Yr 1

$13.5K

Yr 2

$15.7K

Yr 3

$18.3K

Yr 4

$21.3K

Yr 5

$24.7K

Yr 6

$28.8K

Yr 7

$33.5K

Yr 8

$38.9K

Yr 9

$45.3K

Yr 10

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Cash-Flow & Quality Compounder Desk

Cash-Fortress Compounders: Auditing Free Cash Flow & Yield Safety in PNTG & A-Rated Leaders

✓12-month Bull/Base/Bear fair-value walkthrough on PNTG and its top sector peer
✓Top Roarable A-Rated cash compounders with verified executive & 13F accumulation
✓Includes nightly RQD rating-change & forensic signal email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

PNTG // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +33.95%🛡️ HOLDING TREND SUPPORT

2026-11-03O $42.48H $42.48L $41.66C $41.66VOL 367.9K

RES: $43.44SUP: $40.43SMA50: $40.09SMA200: $35.56

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

PNTG Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 PNTG Butterfly Map → + Track PNTG →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

36.5%/yr Implied 5Y Growth

vs. +36.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on PNTG today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for PNTG. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for PNTG today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (PNTG)

Health Care Rank #129 of 1016 ⚔️ TDOC vs PNTG Full Matrix →

1. Head-to-Head Health Care Peer Comparison (PNTG vs. TDOC, USPH, INNV, OMDA)

Industry: Medical/Nursing Services (29 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, The Pennant Group Inc. (PNTG) ranks #129 by composite RQD confidence (64/100, grade C) and #304 by equity capitalization ($1.46B). Within this direct 5-issuer industry benchmark cohort, USPH leads on earnings valuation at 32.6x trailing P/E, while USPH leads on capital efficiency and profitability with 11.5% ROIC and 19.2% gross margin. USPH currently holds the highest overall quantitative score in the immediate peer group at 70/100 (B-) compared with PNTG at 64/100 (C).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
PNTG ACTIVE The Pennant Group Inc.	C	64/100	50.2x	—	11.0%	-1.93%	$1.46B	Benchmark Subject
TDOC Teladoc Health Inc.	D+	55/100	—	—	-17.0%	-2.52%	$1.55B	/tdoc-vs-pntg →
USPH U.S. Physical Therapy Inc.	B-	70/100	32.6x	19.2%	11.5%	-0.85%	$1.28B	/usph-vs-pntg →
INNV InnovAge Holding Corp.	D+	52/100	—	18.0%	-10.2%	-0.54%	$1.25B	/innv-vs-pntg →
OMDA Omada Health Inc.	D+	53/100	—	65.7%	-15.7%	-4.68%	$1.15B	/omda-vs-pntg →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001766400

In its most recent audited fiscal period (FY2025, filed 2025-12-31), The Pennant Group Inc. (PNTG) reported GAAP revenue of $947.7M (+36.3% vs. FY2024 revenue of $695.2M , and +73.9% cumulative change since FY2023) , GAAP net income of $29.6M, operating cash flow of $48.3M, and free cash flow of $36.3M (+19.6% YoY). On the balance sheet, PNTG closed FY2025 with $968.2M in total assets against $0 in total debt (Altman Z-Score: 2.81, Piotroski F-Score: 7/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$947.7M	$29.6M	$48.3M	$36.3M	$968.2M	—
FY2024 (FY)	2024-12-31	$695.2M	$22.6M	$39.3M	$30.3M	$679.5M	—
FY2023 (FY)	2023-12-31	$544.9M	$13.4M	$33.1M	$33.1M	—	—

3. PNTG Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is PNTG stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does PNTG compare to TDOC and USPH in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for PNTG?

Where is PNTG trading relative to its 50-day, 200-day, and 52-week technical levels?

PNTG last traded at $41.66 (-1.93% on volume of 367,916 shares), positioning the stock +3.92% above its 50-day simple moving average ($40.09) and +17.15% above its 200-day simple moving average ($35.56). Across its 52-week range of $22.25 to $43.41, PNTG sits at the 91.7% percentile with a 14-day RSI of 52.7 (NEUTRAL RANGE) and an implied next-earnings move of ±6.2% ($39.08 to $44.24).

PNTG Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Does PNTG pay a dividend and is it safe?

The Pennant Group Inc. (PNTG) offers a 0% cash dividend yield ($0.00 annualized) and 1.8% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

Direct Sub-Reports: PNTG RQD Cockpit PNTG 12M Forecast PNTG Earnings & Move PNTG Dividends & DRIP PNTG Insiders & 13F PNTG Whale Options PNTG Profit Sankey PNTG News & Why

Sector Peer Dials

U.S. Physical Therapy Inc.

70 /100

INNV D+

InnovAge Holding Corp.

GeneDx Holdings Corp. (Class A)

47 /100

ADUS B

Addus HomeCare Corporation

74 /100

PNTG Core Snapshot

Market Cap $1.46B

Trailing / Fwd P/E 50.2x / 42.2x

Gross Profit Margin —

Return on Capital (ROIC) 11.0%

Free Cash Flow Yield 2.44%

12M Base Price Target $42.78

FREE TRADER TOOLS

Own PNTG Alongside Other Stocks? Run a 30-Second Crash X-Ray

Drop 3–5 tickers into our live Portfolio X-Ray to spot hidden accounting time-bombs and see your composite RQD dial.

⚡ X-Ray My Portfolio With PNTG → 🏆 Trade PNTG in $100K Prop Arena →

PNTG Wire

Why It Moved →

Direct Company Event TradingView • 18h ago

The Pennant Group, Inc. Estimates – NASDAQ:PNTG

Peer / Ecosystem Wire Yahoo Finance • 21h ago

1 profitable stock worth your attention and 2 we turn down

Direct Company Event Stock Titan • 1d ago

At Pennant Group (PNTG), 6,624 shares were delivered or withheld to pay the exercise price or tax liability.

Peer / Ecosystem Wire The Globe and Mail • 1d ago

3 Cash-Producing Stocks We Steer Clear Of

Direct Company Event https://www.siam.in/ • 1d ago

Pennant Group (PNTG) Edges 0.83% Lower to $41.88, Testing Mid-Range Support - Gamma Flip Level

ROARABLE RATING BRIEF • RQD 64/100 (C) ✓ STAGE-C NUMBER FIREWALL VERIFIED

PNTG — The Pennant Group Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T15:28:58Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, PNTG scores 67 out of 100 with a letter grade of C+ and a verdict of "Roarable Hold — Upper Neutral / Watch for Breakout." The five pillars are: Fundamental Cash Engine at 13/20 (ROIC 11%; FCF yield 2.44%), Whale 13F Flow at 16/20 (institutional accumulation and options positioning), Insider Conviction at 11/20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit at 13/20 (Beta 1.0; sector sensitivity), and Forensic Balance Sheet at 14/20 (Altman Z 2.81; Piotroski F 7/9; Debt/Equity 0.5).

For a prospective investor, the strongest pillar is institutional flow (16/20), which suggests positioning has been supportive. The weakest pillar is insider conviction (11/20), meaning insider-side signals are the least confirmatory of the five. The cash-generation pillar (13/20) reflects a 2.44% FCF yield alongside an 11% ROIC, which indicates the business is producing returns but not at a level that offsets a high headline multiple. The balance sheet pillar (14/20) is comparatively sound on the cited metrics. The overall grade signals a neutral stance with conditional upside, so the verdict is best read as "wait for confirmation" rather than a directional call. This is an analytical summary, not personalized financial advice.

Snapshot

Price	Market Cap	P/E (TTM)	Forward P/E	EV/EBITDA	EPS (TTM)	Dividend Yield	Beta	52-Wk Range	ROIC %
42.48	$1.48B	50.2	42.2	23.9	0.85	0%	1.0	$22.25 - $43.41	11%

Business

Per the Profile, The Pennant Group Inc. (PNTG) is a NASDAQ-listed issuer in the Health Care sector, Medical/Nursing Services industry, with a market capitalization of $1.5B. Not available in source data for detailed product lines, customer segments, or revenue mechanics. The reported financials show revenue growing from $544.9M (FY 2023) to $947.7M (FY 2025), per the SEC financials.

Recent Catalysts & News Wire Analysis

Per the recent news feed, the items are largely market-wire commentary with no discrete corporate event described in the summaries. Items include a TradingView estimates report, a Yahoo Finance profitability piece, a Stock Titan notice that 6,624 shares were delivered or withheld to pay the exercise price or tax liability, a Globe and Mail piece listing PNTG among "cash-producing" names it avoids, a Google-indexed note of a 0.83% decline to $41.88 near mid-range support, and an ad-hoc-news.de note citing a USD 41.60 analyst consensus. All feed items carry a YELLOW light and MARKET WIRE impact label. Per the Butterfly Supply-Chain Graph, there are no supply-chain links and no proprietary signals. Risk watch items: the share-withholding notice, conflicting market commentary, and the stock trading near a cited consensus figure below the current price.

Open Questions

What are the reported EPS, cash, and debt figures for each period, since the financials table lists these as N/A?
What drives the gap between the 50.2 trailing P/E and the 42.2 forward P/E, and what earnings growth is embedded?
What is the nature and size of the share-withholding event referenced in the news feed?
Who are the institutional and insider holders, and what are their position sizes?
What is the source of the USD 41.60 consensus figure, and how does it compare with the current $42.48 price?

PNTG Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for The Pennant Group Inc. (PNTG) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to PNTG Debate Forum (3) ↓

🟡 MARKET WIRE TradingView • 18h ago

The Pennant Group, Inc. Estimates – NASDAQ:PNTG

TradingView report covering The Pennant Group Inc. (PNTG) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 21h ago

1 profitable stock worth your attention and 2 we turn down

Yahoo Finance report covering The Pennant Group Inc. (PNTG) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Stock Titan • 1d ago

At Pennant Group (PNTG), 6,624 shares were delivered or withheld to pay the exercise price or tax liability.

Stock Titan report covering The Pennant Group Inc. (PNTG) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE The Globe and Mail • 1d ago

3 Cash-Producing Stocks We Steer Clear Of

The Globe and Mail report covering The Pennant Group Inc. (PNTG) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE https://www.siam.in/ • 1d ago

Pennant Group (PNTG) Edges 0.83% Lower to $41.88, Testing Mid-Range Support - Gamma Flip Level

https://www.siam.in/ report covering The Pennant Group Inc. (PNTG) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE ad-hoc-news.de • 1d ago

Analysts set USD 41.60 consensus for The Pennant Group stock

ad-hoc-news.de report covering The Pennant Group Inc. (PNTG) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE ad-hoc-news.de • 1d ago

Truist keeps USD 48.00 target for Pennant Group stock

ad-hoc-news.de report covering The Pennant Group Inc. (PNTG) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST ChartMill • 12d ago

Pennant Group (NASDAQ:PNTG) Meets Minervini Trend Template With High-Growth Momentum

Pennant Group (PNTG) clears Minervini’s Trend Template and high-growth momentum screen, with strong technicals near a 52-week high and a breakout setup.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

PNTG Bull vs. Bear Conversation Board — What's Your Call at $41.66?

🐂 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON PNTG 🐻 50% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk ⚖️ DEBATE HOST 🎯 Target: $45.88 (+8.0%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is PNTG (C+ • RQD 67/100) a Buy at $42.48?

Welcome to the PNTG (The Pennant Group Inc.) Roar Pit. Current RQD Composite is 67/100 (Roarable Hold — Upper Neutral / Watch for Breakout) in Medical/Nursing Services. Bulls point to operating leverage and sector positioning, while bears focus on valuation multiple compression (50.2x trailing P/E). Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

MU MultipleCompression Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $33.56 (-21.0%)

Spot @ $42.48

Pump the brakes on PNTG — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on PNTG, but look at what you are paying: 50.2x trailing P/E with tightening sector spreads. Unless The Pennant Group Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

MA MacroHawk_NYC Verified K Arena Trader 🐂 BULLISH 🎯 Target: $50.55 (+19.0%)

Spot @ $42.48

PNTG cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on PNTG, the market is fixating on short-term headline noise in Medical/Nursing Services and ignoring the balance sheet and cash flow trajectory. At $42.48 (52-wk range $22.25 - $43.41), any beat on forward guidance forces shorts and underweight funds to chase.